Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1 -- 2308 2022-04-08 12:02:34 |
2 format change -19 word(s) 2289 2022-04-08 16:45:13 |

Video Upload Options

Do you have a full video?


Are you sure to Delete?
If you have any further questions, please contact Encyclopedia Editorial Office.
Terasawa, M.; Suzuki, K. Biological Activities of Rhamnan Sulfate. Encyclopedia. Available online: (accessed on 19 April 2024).
Terasawa M, Suzuki K. Biological Activities of Rhamnan Sulfate. Encyclopedia. Available at: Accessed April 19, 2024.
Terasawa, Masahiro, Koji Suzuki. "Biological Activities of Rhamnan Sulfate" Encyclopedia, (accessed April 19, 2024).
Terasawa, M., & Suzuki, K. (2022, April 08). Biological Activities of Rhamnan Sulfate. In Encyclopedia.
Terasawa, Masahiro and Koji Suzuki. "Biological Activities of Rhamnan Sulfate." Encyclopedia. Web. 08 April, 2022.
Biological Activities of Rhamnan Sulfate

Monostroma nitidum is a green single-cell layered algae that grows on the southwest coast of Japan. It is often used for salad ingredients, boiled tsukudani, soups, etc., due to its health benefits. M. nitidum is composed of many cell aggregates, and the various substances that fill the intercellular space are dietary fibers, vitamins, and minerals. Rhamnan sulfate (RS), a sulfated polysaccharide, is main the component of the fiber extracted from M. nitidum. Recently, some biological properties of RS have been demonstrated by in vitro and in vivo studies that probably protect human subjects from viruses and ameliorate vascular dysfunction caused by metabolic disorders, especially lifestyle-related diseases. 

Monostroma nitidum rhamnan sulfate antithrombotic effect antivirus vascular endothelium dysfunction

1. Introduction

Seaweeds have traditionally been consumed by people inhabiting coastal areas in East Asia. Seaweed is rich in vitamins and minerals and is known to have many favorable effects on human health. There are three groups of seaweed, namely green algae, red algae, and brown algae. Green algae contain large amounts of chlorophyll, or green pigments such as those found in terrestrial plants. In contrast, red algae contain, in addition to chlorophyll, plenty of red pigments called phycoerythrin and blue pigments called phycocyanin, giving them a red or purple color [1][2]. Brown algae contain, in addition to chlorophyll, red–brown pigments called fucoxanthin and take on a yellowish brown or blackish brown color. The green alga Monostroma nitidum is often confused with a species of sea lettuces (Ulva Linnaeus). However, M. nitidum and sea lettuce belong to a different order in biological classification. Many species in the group of sea lettuces have a double layer of cells, whereas M. nitidum have a single layer of cell assemblies (Figure 1a,b) [3]. The Japanese name of M. nitidum Hitoegusa is derived from the fact that the leaf-like tissue is composed of a single layer of cells. M. nitidum thallus consists of many cell aggregates (Figure 1c), separated with mucilage rich in dietary fiber, vitamins, minerals, lipids, and peptides [3].
Figure 1. (a) Monostroma nitidum; (b) longitudinal section of the tissue, which is composed of a single layer of cells; (c) tissue consists of many cell aggregates; bar indicates 20 μm.
M. nitidum grows wild in shallow waters along the Pacific coast of Japan (Kii Peninsula, Kyushu, and Nansei Islands), Korean Peninsula, and Southern China. In Japan, seaweed farming is also being practiced in the southwest coastal areas of Mie, Kumamoto, Kagoshima, Nagasaki, and Okinawa prefectures. It is particularly popular in Matoya Bay, Ago Bay, Ise Bay, and Gokasho Bay in Mie Prefecture, accounting for about 70% of the total production in Japan. M. nitidum is a health-promoting food that contains dietary fibers consisting of polysaccharides, minerals, and proteins, and it has been used extensively for nori boiled in soy sauce, miso soups, and salads.

2. Biochemical Characteristics of Rhamnan Sulfate

Cell walls of M. nitidum contain a large amount of rhamnan sulfate (RS), a sulfated polysaccharide [4][5]. Although this macromolecule is poorly soluble in water, it can be solubilized and decomposed into smaller molecules by treating M. nitidum with hot water. The obtained extract is purified by anion-exchange resin column chromatography; sulfated substances bind to the column and are subsequently eluted from the column by increasing the concentration of sodium chloride. This method produces a highly purified RS [5]. Figure 2a shows hot water extract from the intercellular substance of M. nitidum, and Figure 2b shows highly purified RS from M. nitidum.
Figure 2. (a) Hot-water extract from intercellular substance of M. nitidum; (b) highly purified rhamnan sulfate from M. nitidum.
Purified RS is a macromolecular polysaccharide with a molecular weight of tens of thousands to millions. It consists of a polysaccharide with long linear chain structures of α-1,3-linked l-rhamnose connected with α-1,2-linked branched chains, to which several sulfate groups bind (Figure 3) [6][7]; sulfate groups account for about 25% of M. nitidum-derived RS [8].
Figure 3. Chemical structure of rhamnan sulfate (RS) extracted from Monostroma nitidum. RS is a polysaccharide composed of linear chains of l-rhamnose (α-1,3 linkages) with branched chains (α-1,2 linkages), to which several sulfate groups are bound [7].

3. Biological Activities of RS

RS has been reported to have biological activities such as antiviral [6][9][10][11][12][13], anticoagulant [14][15][16][17][18][19][20][21], and antitumor [22] activities. It also induces hyaluronidase inhibition [23], exhibits anti-hypercholesterolemic effect [24][25] suppresses blood glucose elevation [26], and helps with weight control [25]; thus, M. nitidum-derived RS is considered to be involved in many activities in host defense of humans. Table 1 is a summary of the biological activities of RS reported to date.
Table 1. Biological activities of rhamnan sulfate (RS) extract from Monostroma nitidum.

Biological Activity of RS



in vitro study [23]


in vitro study [22]


in vivo study [25]


in vitro study [14][15][16][17][18][19][20][21], in vivo study [16][17]


in vitro study [6][9][10][11][13], in vivo study [12][13]


in vivo study [25], human trial [24]


in vivo study [26], human trial [26]

3.1. Antiviral Effect of RS

Medical researchers have hitherto developed various antiviral medications, including acyclovir, an inhibitor of DNA synthesis used as a medication for herpes simplex virus type 1 and type 2, which cause strong inflammatory responses in the skin, mouth, lips (herpes labialis), eyes, and sex organs, and another medication called oseltamivir, a neuraminidase inhibitor of the influenza virus. However, shortly after their commercialization, these antiviral medications were met with the emergence of drug-resistant viruses, posing a major challenge. It is known that, because these antiviral agents specifically inhibit enzymes of the viruses, they are more likely to induce mutations in the viral DNA or RNA. To overcome this problem, researchers sought to identify and analyze novel substances with antiviral properties that are extracted from naturally derived substances. RS was the outcome of one of those studies [9].
In vitro analysis of the antiviral effect of RS revealed that RS showed suppressing effects on human immunodeficiency virus (HIV), human cytomegalovirus (HCMV), and herpes simplex virus types 1 and 2 (HSV-I and -II) [6][9][10]. Recently, Terasawa et al. showed that RS has an antiviral effect on enveloped viruses, such as measles virus, mump virus, influenza A virus, and human corona virus, but does not affect non-enveloped viruses, such as adenovirus, poliovirus, coxsackie virus, and rhinovirus. Evaluation of the in vitro anti-influenza A virus activity of RS showed that it inhibited both virus adsorption and entry steps to Madin-Darby canine kidney (MDCK) cells [13].
Wang, et al. have shown that intramuscular injection of RS into enterovirus-infected mice significantly improves their survival rate, and RS directly binds to viruses and thereby prevents viral absorption to tissue cells [12], suggesting that it can exert antiviral effects in vivo. Terasawa et al. also showed that oral administration of RS in influenza A virus–infected mice suppressed viral proliferation and weight loss and stimulated neutralizing antibody production in vivo. RS inhibited virus adsorption to the host cells. RS probably binds to the influenza virus hemagglutinin (HA), which is a glycoprotein on the viral envelope and important for host cell binding. Both antiviral and immune stimulating activities of RS may contribute to the suppression of viral proliferation in vivo [13].

3.2. Anti-Obesity and Anti-Hypercholesterolemic Effects of RS

Seaweed contains large amounts of dietary fibers and is reported to lower serum cholesterol levels and neutral fats through carrageenan [27]. Accordingly, to clarify whether the extracted RS, a soluble fiber, is effective for treating obesity and obesity-related diseases, including hepatic steatosis, diabetes, and hyperlipidemia, the zebrafish was used to assess and examine its effects. The zebrafish is a model organism that has been used in recent years to identify and assess drug candidate agents for vertebrates. When zebrafish were rendered obese after being fed a high-fat diet, they doubled their weight compared to normal feeding in four weeks. When switching to a diet containing RS, the weight gain of these obese zebrafish was significantly attenuated [25]. RS also significantly (p < 0.05) mitigated the elevation of serum LDL cholesterol induced by a high-fat diet and prevented fat accumulation in the liver. The gene expression analysis showed that RS mainly inhibits lipogenesis. These results suggest that RS has anti-obesity effects. The researchers conducted a clinical trial on 16 adult males with high cholesterol levels [24]. Their serum cholesterol levels were determined after the study subjects took RS every day for six weeks. As a result, there was no change in serum HDL cholesterol level, but LDL cholesterol level in the RS-treated group was significantly (p < 0.05) reduced compared with that of the group not taking RS. These results suggest that RS keeps the LDL/HDL cholesterol ratio low and prevents lifestyle-related diseases such as obesity and hyperlipidemia.

3.3. Anti-Glycemia Effect of RS

Kamimura et al. [26] reported the effect of edible green algae M. nitidum powder and RS on glycemic responses after oral administration of various saccharinity agents to rats. When rats were administered 2 g of glucose, sucrose, maltose, or soluble starch/kg body weight (b.w.) of rat with or without M. nitidum powder (200 mg/kg b.w. of rat) or RS (approximately 50 mg/kg b.w. of rat), both M. nitidum powder and RS significantly inhibited the increment of plasma glucose level, compared to the controlled group (p < 0.01). Furthermore, they evaluated the effects of M. nitidum powder and RS on the postprandial increase in blood glucose level in healthy human subjects. The results showed the significant deduction of the blood glucose level at 30 min after the intake of M. nitidum powder (500 mg) or RS (approximately 60 mg) compared to the controlled ones (p < 0.05). These data suggest that the M. nitidum powder and RS are useful for diabetes mellitus.
In general, dietary fiber has the effect of suppressing an increase in blood glucose level [28][29], and the mechanisms thereof include (i) delay in the transfer of carbohydrate from the stomach to the duodenum, and (ii) inhibition of carbohydrate digestion and absorption in small intestine. Recently, Terasawa found that RS also has activity to inhibit α-amylase, an enzyme that digests starch to sugar (personal data). The activity may also contribute suppressing an increase in blood glucose level.

3.4. Antithrombotic Effects of RS

Risk factors for the development of thrombosis include aging, various environmental factors, clinical conditions, and stress. Thrombosis is a clinical condition that occurs when a pathological thrombus develops in the blood vessel. Platelet aggregation, blood clotting, and vascular endothelial inflammation are alleged to be three major factors closely related to thrombus formation in blood vessels (Virchow’s triad for thrombosis) (Figure 4) [30][31]. Rudolf K. Virchow in 1856 proposed that there are three essential factors contributing to the formation of arterial and venous thrombosis. They are pathological changes in (1) blood flow, such as abnormal increase and decrease of shear stress; (2) blood components, such as abnormal activation of platelets, blood coagulation, and fibrinolysis factors; and (3) vessel wall, such as abnormal vascular endothelial inflammation. Even today, these three factors are important in understanding the formation of arterial and venous thrombosis, and in developing medicines to treat and prevent thrombotic disorders [32][33].
Figure 4. Virchow’s triad for thrombosis. In 1856, Rudolf K. Virchow proposed three essential factors contributing to the formation of arterial and venous thrombosis. They are pathological changes in blood flow (shear stress), blood components (platelets, coagulation, and fibrinolysis factors), and blood vessel wall (endothelial cell inflammation).

3.5. Anti-Inflammation Effect of RS on Endothelial Cells

It is important to prevent the endothelial inflammation to regulate the onset of thrombotic disorders. To identify the differences between RS and heparin in their effects on inflammation of endothelial cells, the researchers examined whether RS regulates the expression of TF, a trigger of blood coagulation and inflammation, and the platelet aggregating factor VWF in bacteriogenic LPS-induced inflammation of endothelial cells. As shown in Figure 5a, adding LPS induced a marked elevation in TF expression in the endothelial cells, while the TF expression was significantly (p < 0.01) suppressed in the presence of RS in an RS-concentration-dependent manner [14]. Moreover, RS itself significantly suppressed (p < 0.01) the TF expression in endothelial cells not stimulated with LPS in a dose-dependent manner. Similarly, as shown in Figure 5b, LPS significantly induced the expression of VWF in the endothelial cells, and the VWF expression was significantly (p < 0.01) suppressed in the presence of RS in a concentration-dependent manner [14]. Moreover, RS significantly suppressed (p < 0.01) the VWF expression in the endothelial cells not stimulated with LPS in a dose-dependent manner. The effect of heparin was analyzed under the same conditions, and the results showed that, although heparin did not affect the TF expression in the endothelial cells stimulated with LPS, it significantly suppressed (p < 0.01) the TF expression in the endothelial cells not stimulated with LPS (Figure 5c). Unlike RS, heparin enhanced VWF expression in the endothelial cells both in the presence and absence of LPS (Figure 5d). Likewise, RS suppressed significantly the elevation of TF and VWF expression in TNF-α- or thrombin-induced inflammation of endothelial cells, whereas heparin did not show such a suppressing effect (data not shown here) [14]. Overall, unlike heparin, RS was shown to strongly attenuate inflammatory injury in cultured vascular endothelial cells. RS is suggested to be a novel anticoagulant and anti-inflammatory substance for vascular endothelial cells.
Figure 5. (a) Effect of various concentrations of rhamnan sulfate (RS) on tissue factor (TF) expression in HUVECs in the presence (■) or absence (□) of lipopolysaccharides (LPS) (10 μg/mL). (b) Effect of various concentrations of RS on von Willebrand factor (VWF) expression in HUVECs in the presence (■) or absence (□) of LPS (10 μg/mL). (c) Effect of various concentrations of heparin on TF expression in HUVECs in the presence (■) or absence (□) of LPS (10 μg/mL). (d) Effect of various concentrations of heparin on VWF expression in HUVECs in the presence (■) or absence (□) of LPS (10 μg/mL). Significant difference in values between the endothelial cells treated with LPS but without SC and the cells treated with LPS and various concentrations of RS is shown as * p < 0.01. Significant difference in values between the endothelial cells without SC and the cells treated with various concentrations of RS is shown as p < 0.01 [14]


  1. Gitzendanner, M.A.; Soltis, P.S.; Wong, G.K.; Ruhfel, B.R.; Soltis, D.E. Plastid phylogenomic analysis of green plants: A billion years of evolutionary history. Am. J. Bot. 2018, 105, 291–301.
  2. Sanchez-Baracaldo, P.; Raven, J.A.; Pisani, D.; Knoll, A.H. Early photosynthetic eukaryotes inhabited low-salinity habitats. Proc. Natl. Acad. Sci. USA 2017, 114, E7737–E7745.
  3. Marine Organisms Data. Available online: (accessed on 19 March 2020).
  4. Patel, S. Therapeutic importance of sulfated polysaccharides from seaweeds: Updating the recent findings. 3 Biotech. 2012, 2, 171–185.
  5. Lee, J.B.; Yamagaki, T.; Maeda, M.; Nakanishi, H. Rhamnan sulfate from cell walls of Monostroma latissimum. Phytochemistry 1998, 48, 921–925.
  6. Lee, J.B.; Koizumi, S.; Hayashi, K.; Hayashi, T. Structure of rhamnan sulfate from the green alga Monostroma nitidum and its anti-herpetic effect. Carbohydr. Polym. 2010, 81, 572–577.
  7. Tako, M.; Yamashiro, Y.; Teruya, T.; Uechi, S. Structure-function relationship of rhamnan sulfate isolated from commercially cultured edible green seaweed, Monostroma nitidum. Am. J. Appl. Chem. 2017, 5, 38–44.
  8. Nakamura, M.; Yamashiro, Y.; Konishi, T.; Hanasiro, I.; Tako, M. Structural characterization of rhamnan sulfate isolated from commercially cultured Monostroma nitidum (Hitoegusa). J. Jpn. Soc. Food Sci. 2011, 58, 245–251.
  9. Lee, J.B.; Hayashi, K.; Hayashi, T.; Sankawa, U.; Maeda, M. Antiviral activities against HSV-1, HCMV, and HIV-1 of rhamnan sulfate from Monostroma latissimum. Planta Med. 1999, 65, 439–441.
  10. Lee, J.B.; Hayashi, K.; Maeda, M.; Hayashi, T. Antiherpetic activities of sulfated polysaccharides from green algae. Planta Med. 2004, 70, 813–817.
  11. Wang, S.; Wang, W.; Hou, L.; Qin, L.; He, M.; Li, W.; Mao, W. A sulfated glucuronorhamnan from the green seaweed Monostroma nitidum: Characteristics of its structure and antiviral activity. Carbohydr. Polym. 2020, 227, 115280.
  12. Wang, S.; Wang, W.; Hao, C.; Yunjia, Y.; Qin, L.; He, M.; Mao, W. Antiviral activity against enterovirus 71 of sulfated rhamnan isolated from the green alga Monostroma latissimum. Carbohydr. Polym. 2018, 200, 43–53.
  13. Terasawa, M.; Hayashi, K.; Lee, J.B.; Nishiura, K.; Matsuda, K.; Hayashi, T.; Kawahara, T. Anti-influenza A virus activity of rhamnan sulfate from green algae Monostroma nitidum in mice with normal and compromised immunity. (unpublished but already submitted).
  14. Okamoto, T.; Akita, N.; Terasawa, M.; Hayashi, T.; Suzuki, K. Rhamnan sulfate extracted from Monostroma nitidum attenuates blood coagulation and inflammation of vascular endothelial cells. J. Nat. Med. 2019, 73, 614–619.
  15. Liu, X.; Hao, J.; He, X.; Wang, S.; Cao, S.; Qin, L.; Mao, W. A rhamnan-type sulfated polysaccharide with novel structure from Monostroma angicava Kjellm (Chlorophyta) and its bioactivity. Carbohydr. Polym. 2017, 173, 732–748.
  16. Liu, X.; Du, P.; Liu, X.; Cao, S.; Qin, L.; He, M.; He, X.; Mao, W. Anticoagulant properties of a green algal rhamnan-type sulfated polysaccharide and its low-molecular-weight fragments prepared by mild acid degradation. Mar. Drugs 2018, 16, 445.
  17. Liu, X.; Wang, S.; Cao, S.; He, X.; Qin, L.; He, M.; Yang, Y.; Hao, J.; Mao, W. Structural characteristics and anticoagulant property in vitro and in vivo of a seaweed sulfated rhamnan. Mar. Drugs 2018, 16, 243.
  18. Li, H.; Mao, W.; Hou, Y.; Gao, Y.; Qi, X.; Zhao, C.; Chen, Y.; Chen, Y.; Li, N.; Wang, C. Preparation, structure and anticoagulant activity of a low molecular weight fraction produced by mild acid hydrolysis of sulfated rhamnan from Monostroma latissimum. Bioresour. Technol. 2012, 114, 414–418.
  19. Li, N.; Liu, X.; He, X.; Wang, S.; Cao, S.; Xia, Z.; Xian, H.; Qin, L.; Mao, W. Structure and anticoagulant property of a sulfated polysaccharide isolated from the green seaweed Monostroma angicava. Carbohydr. Polym. 2017, 159, 195–206.
  20. Harada, N.; Maeda, M. Chemical structure of antithrombin-active rhamnan sulfate from Monostrom nitidum. Biosci. Biotechnol. Biochem. 1998, 62, 1647–1652.
  21. Li, H.; Mao, W.; Zhang, X.; Qi, X.; Chen, Y.; Chen, Y.; Xu, J.; Zhao, C.; Hou, Y.; Yang, Y.; et al. Structural characterization of an anticoagulant-active sulfated polysaccharide isolated from green alga Monostroma latissimum. Carbohydr. Polym. 2011, 85, 394–400.
  22. Ropellato, J.; Carvalho, M.M.; Ferreira, L.G.; Noseda, M.D.; Zuconelli, C.R.; Goncalves, A.G.; Ducatti, D.R.; Kenski, J.C.; Nasato, P.L.; Winnischofer, S.M.; et al. Sulfated heterorhamnans from the green seaweed Gayralia oxysperma: Partial depolymerization, chemical structure and antitumor activity. Carbohydr. Polym. 2015, 117, 476–485.
  23. Yamamoto, Y.; Ozono, M.; Oishi, T.; Oshima, K.; Mitsuiki, S.; Kakihara, H.; Mukae, K. Hyaluronidase-inhibitory activity of rhamnan sulfate obtained from cultivated Monostroma nitidum (Hitoegusa). J. Jpn. Soc. Food Sci. 2016, 63, 545–549.
  24. Nishikawa, M.; Mitsui, M.; Umeda, K.; Kitaoka, Y.; Takahashi, Y.; Tanaka, S. Effect of sulfated polysaccharides extracted from sea alga (Monostroma latissium and Monostroma nitidum) on serum cholesterol in subjects with borderline or mild hypercholesterolemia. J. New Rem. Clin. 2006, 55, 1763–1770.
  25. Zang, L.; Shimada, Y.; Tanaka, T.; Nishimura, N. Rhamnan sulphate from Monostroma nitidum attenuates hepatic steatosis by suppressing lipogenesis in a diet-induced obesity zebrafish model. J. Funct. Foods 2015, 17, 364–370.
  26. Kamimura, Y.; Hashiguchi, K.; Nagata, Y.; Saka, T.; Yoshida, M.; Makino, Y.; Amano, H. Inhibitory effects of edible green algae Monostroma nitidum on glycemic responses. J. Jpn. Soc. Food Sci. 2010, 57, 441–445.
  27. Panlasigui, L.N.; Baello, O.Q.; Dimatangal, J.M.; Dumelod, B.D. Blood cholesterol and lipid-lowering effects of carrageenan on human volunteers. Asia Pac. J. Clin. Nutr. 2003, 12, 209–214.
  28. Fuller, S.; Beck, E.; Salman, H.; Tapsell, L. New horizons for the study of dietary fiber and health: A Review. Plant Foods Hum. Nutr. 2016, 71, 1–12.
  29. Yu, K.; Ke, M.Y.; Li, W.H.; Zhang, S.Q.; Fang, X.C. The impact of soluble dietary fibre on gastric emptying, postprandial blood glucose and insulin in patients with type 2 diabetes. Asia Pac. J. Clin. Nutr. 2014, 23, 210–218.
  30. Kumar, D.R.; Hanlin, E.; Glurich, I.; Mazza, J.J.; Yale, S.H. Virchow’s contribution to the understanding of thrombosis and cellular biology. Clin. Med. Res. 2010, 8, 168–172.
  31. Bagot, C.N.; Arya, R. Virchow and his triad: A question of attribution. Br. J. Haematol. 2008, 143, 180–190.
  32. Watson, T.; Shantsila, E.; Lip, G.Y. Mechanisms of thrombogenesis in atrial fibrillation: Virchow’s triad revisited. Lancet 2009, 373, 155–166.
  33. Hosseinzadegan, H.; Tafti, D.K. Prediction of Thrombus Growth: Effect of Stenosis and Reynolds Number. Cardiovasc. Eng. Technol. 2017, 8, 164–181.
Contributors MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to : ,
View Times: 712
Revisions: 2 times (View History)
Update Date: 08 Apr 2022